Not necessarily every single patient immediately, but anyone with known retinopathy, symptoms, or overdue retinal screening should strongly consider an updated exam
* In solvent : -80C, 1 year
Some users abandon protocols prematurely and miss out on benefits that would have developed with continued use
The trial included 3,183 patients with type 2 diabetes and established cardiovascular disease, chronic kidney disease, or both, who were randomized to receive either oral semaglutide (14 mg) once daily or placebo
Semaglutide-eye-catching results
Se recomienda tomar 3 cpsulas al dia, preferentemente, una hora antes del ejercicio